Clinical Trial

Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)

Study acronym: Hypo-OPRA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The combination of preoperative pelvic RT - either long-course chemoradiotherapy (LCCRT) or short-course radiotherapy (SCRT)- followed by surgery has been the standard of care in the curative treatment of locally advanced adenocarcinoma of the rectum for decades. Some patients however achieve a complete clinical response (cCR) to their preoperative treatment which opens the possibility of avoiding surgery and consequently preserving the rectum. There now exists a growing body of data from centres around the world validating the safety of a surveillance approach in clinical complete responders treated with LCCRT.
Trial Details
NCT Number NCT06991465
Lead Sponsor Neil Kopek
Collaborators: McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions Colorectal Carcinoma
Enrollment 35 participants
Start Date 2023-08-16
Primary Completion 2027-09 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-28